OPKO Health, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OPKO Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $0.00.
- OPKO Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-12-31 was $0.00.
- OPKO Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-09-30 was $0.00.
- OPKO Health, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-06-30 was $55.27M.
- OPKO Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $55.27M.
- OPKO Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $50.85M.
- OPKO Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2011 was $1.74M.
- OPKO Health, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2009 was -$1.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $55.27M 10-K · filed 2024-03-01 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | |
| 2021-06-30 | $55.27M 10-Q · filed 2022-08-04 | |
| 2019-12-31 | $50.85M 10-K · filed 2022-03-01 | |
| 2011-12-31 | $1.74M 10-K · filed 2012-03-15 | |
| 2009-12-31 | -$1.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |